Media Library

Access photos, images, or videos for stories in development. If you are a member of the working press and need a resource that is not available on this website, please e-mail your request to media@bms.com and we will make every effort to respond as soon as possible. Please read our terms for usage.

As of March 5, we've updated our corporate brand. We are in the process of updating our media library - in the meantime, please find new materials below.

Key Facts

updated Jan 2019

Chief Executive Officer:

Giovanni Caforio, M.D.

Headquarters:

New York City

Business:

Biopharmaceuticals

Web Address:

alintour.com

NYSE Listing:

BMY

Net Sales:

$22.6 billion in 2018

R&D Investment:

$5.1 billion* which included the discovery and development of new medicines for patients

*This non-GAAP amount excludes significant upfront and milestone payments for business development transactions and other specified R&D items.

2018 Largest-Selling Brands:

OPDIVO^®, $6.7 billion

ELIQUIS^®, $6.4 billion

ORENCIA^®câu lạc bộ nohu88, $2.7 billion

SPRYCEL^®, $2.0 billion

YERVOY^®, $1.3 billion

BARACLUDE^®câu lạc bộ nohu88, $744 million

SUSTIVA^®câu lạc bộ nohu88 franchise, $283 million

REYATAZ^® franchise, $427 million

Hepatitis C franchise, $17 million

Selected Key Products:

BARACLUDE^® (entecavir)

SUSTIVA^® (efavirenz)

Please click on the product links to see the Full Prescribing Information for , ,, , , , , , , and , including Boxed WARNINGS for , , and Boxed WARNINGS for regarding immune-mediated adverse reaction.

Bristol Myers Squibb Corporate B-roll

Overview B-roll

This B-roll includes a collection of footage of Bristol Myers Squibb campus exteriors, corporate signage, research and development, and manufacturing facilities.